- Filed
- Oct 30, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | Q3 2024 · Sep 30, 2024 | $25.52M |
| Short Term Investments | Q3 2024 · Dec 31, 2023 | $32.67M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $22.79M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $20.42M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $16.17M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $18.65M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $31.12M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $32.72M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $68.62M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $72.24M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $155.17M |
| Total Assets | Q3 2024 · Sep 30, 2023 | $150.75M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 8.12M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 8.07M sh |
| Stock Repurchased | Q3 2024 · Sep 30, 2023 | $0 |
| Dividends Paid | Q3 2024 · Sep 30, 2023 | $4.27M |
| Capex | Q3 2024 · Sep 30, 2023 | $119K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$5.68M |
| Stockholders Equity restated | Q3 2024 · Sep 30, 2023 | $119.8M |
| Stockholders Equity | Q3 2024 · Jun 30, 2022 | $115.1M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.41 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.86 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.42 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.87 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $3.3M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $9.58M |
| Net Income | Q3 2024 · Sep 30, 2023 | $3.36M |
| Net Income | Q3 2024 · Sep 30, 2023 | $6.94M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$1.45M |
| Operating Income | Q3 2024 · Sep 30, 2023 | $3.16M |
| Revenue | Q3 2024 · Sep 30, 2023 | $21.88M |
| Revenue | Q3 2024 · Sep 30, 2023 | $66.55M |